Friday, May 1, 2026

North Korea’s Military Strategy: Is the Second Economic Committee Now Under Cabinet Control?

North Korea may have integrated its military-focused Second Economic Committee into the Cabinet, enhancing military production oversight.

$8,000,000 SLUSH FUND: Lee’s Inner Circle Funded North Korea—The Best Way To Betray Your Own Nation

Democratic lawmakers demand investigation into alleged testimony fabrication in the Ssangbangwool North Korea remittance case amid ongoing probes.

Kim Ha Seong Joins Tampa Bay Rays for $29 Million, Highest Salary for Team in Recent History

Kim Ha Seong signs a $29M contract with the Tampa Bay Rays, marking their highest free-agent investment in 26 years.

Tag: production

Discover the Breakthroughs of Korea’s ARPA-H Project at BIO KOREA 2026!

The K-Health Future Promotion Team will unveil interim results of the Korean-style ARPA-H project at BIO KOREA 2026, addressing healthcare challenges.

$75M Bet on Next-Gen Chips: Hanmi Unveils Hybrid Bonder for HBM

Hanmi Semiconductor will launch a 2nd Gen Hybrid Bonder for HBM production and invest $75M in a new factory to meet rising demand.

Revolutionary Male Contraceptive: New Method Halts Sperm Production Without Hormonal Side Effects

A Cornell team developed a reversible male contraceptive, blocking sperm production without hormonal side effects, using a compound called JQ1.

South Korea Government Response: Quick Solutions to Naphtha Supply Issues for Medical Materials

South Korea's government is expediting approvals for medical supply production amid naphtha supply issues, easing industry concerns.

How KAIST’s Quinone-Titanium Catalyst Could Transform Energy Production in 2026

A KAIST research team developed a stable molecular catalyst combining quinone and titanium, enhancing artificial energy production methods.

Celltrion’s 1 Trillion KRW Investment: A Game Changer for Biopharmaceutical Production by 2030

Celltrion plans a major expansion with over 1 trillion KRW investment, boosting production capacity for biosimilars and new drugs by 2030.

Estipam Secures Record 897 Billion KRW Contract for Oligonucleotide Raw Materials: What This Means for the Asian Market

ST Pharm secures a record 89.7 billion KRW contract for oligonucleotide ingredients, enhancing its global market position.

China Set to Overtake South Korea in OLED Production by 2029

China's OLED production is set to surpass South Korea's by 2029, driven by aggressive investments and growth in display technology.

Samsung Biologics CEO John Rim Poised for Third Term: What This Means for the Global CDMO Market in 2026

John Rim of Samsung Biologics aims for a third term, leading record growth and expansion into next-gen therapies amid global challenges.

CGBio’s NovoFactory: A Game-Changer for Bone Graft Products in the U.S. and Japan

CGBio's new Novo Factory in Hwaseong receives approval to produce Novosis Putty, targeting advanced markets like the U.S. and Japan.

Samsung Biologics: How a 56 Billion USD CDMO Leader is Shaping the Future of Biopharmaceuticals

Samsung Biologics is evolving as a leading CDMO, targeting a production capacity of 1.32M liters by 2030 after its spin-off from Bioepis.

Hyderabad’s New CKD Production Line: How Huons Meditech and Vasu Group are Revolutionizing Endoscope Sterilizers in India

Huons Meditech inaugurated a CKD production line for endoscope disinfectors in India, enhancing local production and market expansion.

Samsung Biologics Partners with CEPI: A Game-Changer for Global Vaccine Production

Samsung Biologics partners with CEPI to enhance vaccine production for pandemics, aiming for rapid global supply and health security.

Samsung Biologics Unveils Three-Pillar Growth Strategy: How Capacity, Portfolio, and Global Expansion Shape 2026

Samsung Biologics outlines a growth strategy focused on production, portfolio, and global expansion to enhance its CDMO position.

Top News

- Our Sponsors Ad -

Follow us